Ken Griffin Idexx Laboratories Inc Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 48,800 shares of IDXX stock, worth $24.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,800

Previous 40,900 19.32%

Holding current value

$24.7 Million

Previous $22.1 Million 7.66%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$468.04 - $548.53 $16.4 Million - $19.3 Million	35,125 Added 83.14%	77,372 $37.7 Million
Q1 2024 May 15, 2024	SELL	$515.08 - $576.87 $51.3 Million - $57.5 Million	-99,625 Reduced 70.22%	42,247 $22.8 Million
Q4 2023 Feb 14, 2024	BUY	$391.37 - $557.56 $37.8 Million - $53.9 Million	96,605 Added 213.41%	141,872 $78.7 Million
Q3 2023 Nov 14, 2023	SELL	$432.42 - $556.67 $24.9 Million - $32.1 Million	-57,667 Reduced 56.02%	45,267 $19.8 Million
Q2 2023 Aug 14, 2023	SELL	$450.7 - $503.61 $274 Million - $307 Million	-608,965 Reduced 85.54%	102,934 $51.7 Million
Q1 2023 May 15, 2023	BUY	$406.01 - $514.59 $127 Million - $161 Million	313,801 Added 78.83%	711,899 $356 Million
Q4 2022 Feb 14, 2023	BUY	$324.64 - $441.27 $9.66 Million - $13.1 Million	29,767 Added 8.08%	398,098 $162 Million
Q3 2022 Nov 14, 2022	BUY	$325.8 - $407.78 $86 Million - $108 Million	264,023 Added 253.12%	368,331 $120 Million
Q2 2022 Aug 15, 2022	BUY	$327.37 - $553.44 $33.6 Million - $56.7 Million	102,533 Added 5776.51%	104,308 $36.6 Million
Q1 2022 May 16, 2022	SELL	$466.52 - $631.01 $152,552 - $206,340	-327 Reduced 15.56%	1,775 $971,000
Q4 2021 Feb 14, 2022	SELL	$586.54 - $666.48 $27 Million - $30.6 Million	-45,973 Reduced 95.63%	2,102 $1.38 Million
Q3 2021 Nov 15, 2021	BUY	$621.9 - $705.76 $14.6 Million - $16.5 Million	23,432 Added 95.09%	48,075 $29.9 Million
Q1 2021 May 17, 2021	SELL	$465.18 - $551.79 $3.26 Million - $3.87 Million	-7,009 Reduced 22.14%	24,643 $12.1 Million
Q4 2020 Feb 16, 2021	SELL	$383.85 - $499.87 $57.9 Million - $75.4 Million	-150,908 Reduced 82.66%	31,652 $15.8 Million
Q3 2020 Nov 16, 2020	BUY	$334.54 - $406.31 $58.2 Million - $70.7 Million	173,899 Added 2007.84%	182,560 $71.8 Million
Q2 2020 Aug 14, 2020	BUY	$230.66 - $330.16 $1.14 Million - $1.63 Million	4,930 Added 132.14%	8,661 $2.86 Million
Q1 2020 May 15, 2020	SELL	$182.94 - $290.97 $367,160 - $583,976	-2,007 Reduced 34.98%	3,731 $904,000
Q2 2019 Aug 14, 2019	SELL	$215.53 - $275.33 $4.87 Million - $6.22 Million	-22,590 Reduced 79.74%	5,738 $1.58 Million
Q4 2018 Feb 14, 2019	BUY	$176.18 - $248.92 $1.99 Million - $2.81 Million	11,301 Added 66.37%	28,328 $5.27 Million
Q3 2018 Nov 13, 2018	SELL	$218.82 - $254.46 $1.54 Million - $1.79 Million	-7,022 Reduced 29.2%	17,027 $0
Q2 2018 Aug 10, 2018	SELL	$185.56 - $227.9 $10.3 Million - $12.6 Million	-55,446 Reduced 69.75%	24,049 $0
Q1 2018 May 11, 2018	BUY	$157.81 - $204.73 $5.39 Million - $7 Million	34,182 Added 75.44%	79,495 $15.2 Million
Q4 2017 Feb 09, 2018	BUY	$147.68 - $168.37 $5.99 Million - $6.83 Million	40,562 Added 853.76%	45,313 $7.09 Million
Q3 2017 Nov 09, 2017	BUY	$150.32 - $166.46 $714,170 - $790,851	4,751	4,751 $739,000

Others Institutions Holding IDXX

# of Institutions

1,200

Shares Held

75.5M

Call Options Held

176K

Put Options Held

284K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $42.2B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account